A Comparison of the Effects of Neuronal Nitric Oxide Synthase and Inducible Nitric Oxide Synthase Inhibition on Cartilage Damage

Overview

Journal Biomed Res Int

Publisher Wiley

Specialties Biomedical Engineering
Biotechnology
General Medicine

Date 2016 Jul 7

PMID 27382570

Citations 7

Authors

Nevzat Selim Gokay

Ibrahim Yilmaz

Baran Komur

Ahu Senem Demiroz

Alper Gokce

Sergulen Dervisoglu

Banu Vural Gokay

Affiliations

Soon will be listed here.

Abstract

The objective of this study was to investigate the effects of selective inducible nitric oxide synthase and neuronal nitric oxide synthase inhibitors on cartilage regeneration. The study involved 27 Wistar rats that were divided into five groups. On Day 1, both knees of 3 rats were resected and placed in a formalin solution as a control group. The remaining 24 rats were separated into 4 groups, and their right knees were surgically damaged. Depending on the groups, the rats were injected with intra-articular normal saline solution, neuronal nitric oxide synthase inhibitor 7-nitroindazole (50 mg/kg), inducible nitric oxide synthase inhibitor amino-guanidine (30 mg/kg), or nitric oxide precursor L-arginine (200 mg/kg). After 21 days, the right and left knees of the rats were resected and placed in formalin solution. The samples were histopathologically examined by a blinded evaluator and scored on 8 parameters. Although selective neuronal nitric oxide synthase inhibition exhibited significant (P = 0.044) positive effects on cartilage regeneration following cartilage damage, it was determined that inducible nitric oxide synthase inhibition had no statistically significant effect on cartilage regeneration. It was observed that the nitric oxide synthase activation triggered advanced arthrosis symptoms, such as osteophyte formation. The fact that selective neuronal nitric oxide synthase inhibitors were observed to have mitigating effects on the severity of the damage may, in the future, influence the development of new agents to be used in the treatment of cartilage disorders.

Citing Articles

Comparative Metabolomics Study Revealed Difference in Central Carbon Metabolism between Sika Deer and Red Deer Antler.

Su H, Yang C, Jin C, Zhang H, Yin C, Yang Y Int J Genomics. 2020; 2020:7192896.

PMID: 32908856 PMC: 7471787. DOI: 10.1155/2020/7192896.

Neuroprotection mediated by natural products and their chemical derivatives.

Fei F, Su N, Li X, Fei Z Neural Regen Res. 2020; 15(11):2008-2015.

PMID: 32394948 PMC: 7716029. DOI: 10.4103/1673-5374.282240.

Investigation of the effect of dipyrone on cells isolated from intervertebral disc tissue.

Akgun F, Sirin D, Yilmaz I, Karaarslan N, Ozbek H, Simsek A Exp Ther Med. 2019; 18(1):216-224.

PMID: 31258656 PMC: 6566084. DOI: 10.3892/etm.2019.7576.

The Link Between Inflammaging and Degenerative Joint Diseases.

Rezus E, Cardoneanu A, Burlui A, Luca A, Codreanu C, Tamba B Int J Mol Sci. 2019; 20(3).

PMID: 30708978 PMC: 6386892. DOI: 10.3390/ijms20030614.

Serum levels of total antioxidant status, nitric oxide and nitric oxide synthase in minor recurrent aphthous stomatitis patients.

Zhang Z, Zhang Q, Xue Y, Chen G, Wu Z, Fang H Medicine (Baltimore). 2019; 98(3):e14039.

PMID: 30653111 PMC: 6370179. DOI: 10.1097/MD.0000000000014039.

References

Westacott C, Sharif M . Cytokines in osteoarthritis: mediators or markers of joint destruction?. Semin Arthritis Rheum. 1996; 25(4):254-72. DOI: 10.1016/s0049-0172(96)80036-9. View

Pozza M, Bettelli C, Magnani F, Mascia M, Manzini E, Calza L . Is neuronal nitric oxide involved in adjuvant-induced joint inflammation?. Eur J Pharmacol. 1998; 359(1):87-93. DOI: 10.1016/s0014-2999(98)00618-9. View

Bezerra M, Brain S, Greenacre S, Jeronimo S, de Melo L, Keeble J . Reactive nitrogen species scavenging, rather than nitric oxide inhibition, protects from articular cartilage damage in rat zymosan-induced arthritis. Br J Pharmacol. 2003; 141(1):172-82. PMC: 1574182. DOI: 10.1038/sj.bjp.0705600. View

Gerwin N, Bendele A, Glasson S, Carlson C . The OARSI histopathology initiative - recommendations for histological assessments of osteoarthritis in the rat. Osteoarthritis Cartilage. 2010; 18 Suppl 3:S24-34. DOI: 10.1016/j.joca.2010.05.030. View

Gencosmanoglu B, Eryavuz M, Dervisoglu S . Effects of some nonsteroidal anti-inflammatory drugs on articular cartilage of rats in an experimental model of osteoarthritis. Res Exp Med (Berl). 2001; 200(3):215-26. View

Stadler J, Stefanovic-Racic M, Billiar T, Curran R, McIntyre L, Georgescu H . Articular chondrocytes synthesize nitric oxide in response to cytokines and lipopolysaccharide. J Immunol. 1991; 147(11):3915-20. View

Nussler A, Di Silvio M, Billiar T, Hoffman R, Geller D, Selby R . Stimulation of the nitric oxide synthase pathway in human hepatocytes by cytokines and endotoxin. J Exp Med. 1992; 176(1):261-4. PMC: 2119287. DOI: 10.1084/jem.176.1.261. View

Abramson S . Osteoarthritis and nitric oxide. Osteoarthritis Cartilage. 2008; 16 Suppl 2:S15-20. DOI: 10.1016/S1063-4584(08)60008-4. View

Hellio le Graverand M, Clemmer R, Redifer P, Brunell R, Hayes C, Brandt K . A 2-year randomised, double-blind, placebo-controlled, multicentre study of oral selective iNOS inhibitor, cindunistat (SD-6010), in patients with symptomatic osteoarthritis of the knee. Ann Rheum Dis. 2012; 72(2):187-95. DOI: 10.1136/annrheumdis-2012-202239. View

10.

Paolucci C, Rovere P, De Nadai C, Manfredi A, Clementi E . Nitric oxide inhibits the tumor necrosis factor alpha -regulated endocytosis of human dendritic cells in a cyclic GMP-dependent way. J Biol Chem. 2000; 275(26):19638-44. DOI: 10.1074/jbc.M000511200. View

11.

Falcone S, Perrotta C, De Palma C, Pisconti A, Sciorati C, Capobianco A . Activation of acid sphingomyelinase and its inhibition by the nitric oxide/cyclic guanosine 3',5'-monophosphate pathway: key events in Escherichia coli-elicited apoptosis of dendritic cells. J Immunol. 2004; 173(7):4452-63. DOI: 10.4049/jimmunol.173.7.4452. View

12.

Jang D, Murrell G . Nitric oxide in arthritis. Free Radic Biol Med. 1998; 24(9):1511-9. DOI: 10.1016/s0891-5849(97)00459-0. View

13.

Sakurai H, Kohsaka H, Liu M, Higashiyama H, Hirata Y, Kanno K . Nitric oxide production and inducible nitric oxide synthase expression in inflammatory arthritides. J Clin Invest. 1995; 96(5):2357-63. PMC: 185887. DOI: 10.1172/JCI118292. View

14.

Yan Q, Feng Q, Beier F . Reduced chondrocyte proliferation, earlier cell cycle exit and increased apoptosis in neuronal nitric oxide synthase-deficient mice. Osteoarthritis Cartilage. 2011; 20(2):144-51. DOI: 10.1016/j.joca.2011.11.014. View

15.

Castro R, Cunha F, Silva Jr F, Rocha F . A quantitative approach to measure joint pain in experimental osteoarthritis--evidence of a role for nitric oxide. Osteoarthritis Cartilage. 2006; 14(8):769-76. DOI: 10.1016/j.joca.2006.01.013. View

16.

Tamura T, Nakanishi T, Kimura Y, Hattori T, Sasaki K, Norimatsu H . Nitric oxide mediates interleukin-1-induced matrix degradation and basic fibroblast growth factor release in cultured rabbit articular chondrocytes: a possible mechanism of pathological neovascularization in arthritis. Endocrinology. 1996; 137(9):3729-37. DOI: 10.1210/endo.137.9.8756539. View

17.

Melchiorri C, Meliconi R, Frizziero L, Silvestri T, Pulsatelli L, Mazzetti I . Enhanced and coordinated in vivo expression of inflammatory cytokines and nitric oxide synthase by chondrocytes from patients with osteoarthritis. Arthritis Rheum. 1998; 41(12):2165-74. DOI: 10.1002/1529-0131(199812)41:12<2165::AID-ART11>3.0.CO;2-O. View

18.

Fermor B, Weinberg J, Pisetsky D, Misukonis M, Banes A, Guilak F . The effects of static and intermittent compression on nitric oxide production in articular cartilage explants. J Orthop Res. 2001; 19(4):729-37. DOI: 10.1016/S0736-0266(00)00049-8. View

19.

St Clair E . Nitric oxide--friend or foe in arthritis?. J Rheumatol. 1998; 25(8):1451-3. View

20.

Ramage L, Martel M, Hardingham G, Salter D . NMDA receptor expression and activity in osteoarthritic human articular chondrocytes. Osteoarthritis Cartilage. 2008; 16(12):1576-84. DOI: 10.1016/j.joca.2008.04.023. View